Latest News and Press Releases

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in Agentic Commerce and AI-powered retail infrastructure, today announced it will showcase its end-to-end...

ClearlyRated® announces the firms that have qualified for inclusion on its fourth annual Best Staffing Firms for Women™ list

IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food...

BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve as an...

Sunday raises $165M at a $1.15B valuation to launch Memo, its autonomous home robot into households this Fall. The round is led by Coatue.

BOCA RATON, FL, March 10, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana...

10 March 2026 ICG plc (“ICG” or the “Company”) Board Changes The Board of ICG announces that Jonathon Bond has been appointed as an Independent Non-Executive Director of the Company. He will join...

此次合作依托Tenacia在中枢神经系统（CNS）药物开发与商业化方面的专长，加速RAP-219在美国及全球的开发进程 Tenacia获得大中华区RAP-219开发和商业化的独家权利，针对病症包括局灶性发作癫痫和双相躁狂等适应症 Rapport将获得2000万美元的现金预付款，最高可达3.08亿美元的潜在开发与商业化里程碑款项及其他付款，以及个位数中段到十几中段的分级特许权使用费 ...

Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China

CHARLESTOWN, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases,...